Insiders Taysha Gene Therapies, Inc.

Equities

TSHA

US8776191061

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
2.45 ^USD	+2.51%		-0.41%	+38.42%

Apr. 09	Piper Sandler Initiates Taysha Gene Therapies at Overweight Rating With $9 Price Target	MT
Mar. 21	Chardan Adjusts PT on Taysha Gene Therapies to $7 From $5 as Gene Therapy for Rett Syndrome Shows 'Sustained Benefit', Keeps Buy Rating	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Taysha Gene Therapies Insider Bought Shares Worth $163,000, According to a Recent SEC Filing	Nov. 20	MT
Taysha Gene Therapies, Inc. Appoints Alison Long to Board and Committees	Nov. 01	CI
Pliant Therapeutics Appoints Chief Regulatory Officer	23-10-16	MT
Insider Buy: Taysha Gene Therapies	23-08-17	MT
Taysha Gene Therapies, Inc. Announces Board Changes	23-06-22	CI
Taysha Gene Therapies, Inc. Announces Resignation of Kathleen Reape as Director, Effective November 1, 2023	23-04-27	CI
Taysha Gene Therapies, Inc. Announces Resignation of R.A. Session II from the Board and All Committees	23-03-08	CI
Taysha Gene Therapies, Inc. Announces Separation Suyash Prasad as Chief Medical Officer	23-01-19	CI
Taysha Gene Therapies Appoints Sean Nolan as CEO	22-12-19	MT
Taysha Gene Therapies, Inc. Appoints Sukumar Nagendran, M.D. as President and Head of R&D	22-12-16	CI
Taysha Gene Therapies Announces CEO Changes	22-12-16	CI
Insider Buy: Taysha Gene Therapies	22-02-04	MT
Insider Buy: Taysha Gene Therapies	21-11-24	MT
Taysha Gene Therapies Appoints Mary Newman as Chief Development Officer	21-05-13	CI
Taysha Gene Therapies Announces Formation of Independent Scientific Advisory Board	21-02-16	CI
Taysha Gene Therapies, Inc. Appoints Timothy J. Douros as Chief Legal Officer and Corporate Secretary and Tracy M. Porter as Chief People Officer	21-01-26	CI
Taysha Gene Therapies, Inc. Announces Executive Appointments	20-12-29	CI
Taysha Gene Therapies Names Kathy Reape and Laura Sepp-Lorenzino to Board of Directors	20-12-07	CI
Taysha Gene Therapies, Inc Announces Directors Appointments	20-11-24	CI
Taysha Gene Therapies, Inc. Announces Appointments to the Board and Appoints Phillip Donenberg to Serve as Audit Committee Chairman	20-08-31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Taysha Gene Therapies, Inc.

Equities

TSHA

US8776191061

Insiders

Filters